Topics

"Tumors Wounds That Heal Historical Perspective with Focus∨derfield=date∨derval=DESC" News Stories

02:30 EDT 19th July 2019 | BioPortfolio

Here are the most relevant search results for "Tumors Wounds That Heal Historical Perspective with Focus∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Tumors Wounds That Heal Historical Perspective with Focus∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Tumors Wounds That Heal Historical Perspective with Focus∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Tumors Wounds That Heal Historical Perspective with Focus∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Tumors Wounds That Heal Historical Perspective with Focus∨derfield=date∨derval=DESC Companies for you to search.

Showing "Tumors Wounds That Heal Historical Perspective with Focus" News Articles 1–25 of 7,900+

Friday 19th July 2019

Algiax Pharmaceuticals appoints Prof. Claudia Sommer and Dr. Klaus-Dieter Langner to join its Scientific Advisory Board

Clinical neuropathic pain expert Prof. Sommer and long-time pain pharma industry expert Dr. Langner to consult Algiax Pharmaceuticals in the development of AP-325 and further assetts. Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for neuropathic pain and other indications with unmet medical need, announced the appointment of Pr...


Thursday 18th July 2019

Agilent expands cell analysis portfolio with BioTek acquisition

Agilent Technologies has signed a definitive agreement to acquire the privately owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. Headquartered in Vermont, USA, BioTek is a designer, manufacturer and distributor of innovative life science instrumentation. Its comprehensive product line incl...

CMS Establishes 2019 Monthly Fee Schedule Amount for Optune®

Novocure (NASDAQ: NVCR) today announced the U.S Centers for Medicare & Medicaid Services (CMS) has established a 2019 monthly fee schedule amount for Optune. Additional details on the fee schedule amount and pricing methodology are available on the CMS website. The announcement by CMS follows an announcement earlier this morning by the durable medical equipment (DME) Medicare Administrative...


Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters

€400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b Medicxi III will invest across the full healthcare continuum, from discovery to late stage clinical assets, empowering ambitious scientific entrepreneurs and drug hunters Novartis and Johnson & Johnson Innovation – JJDC, Inc. are returning cornerstone inv...

Flex Pharma Announces Rights Dividend

Flex Pharma, Inc. (Nasdaq: FLKS) announced that its Board of Directors today declared a special dividend on the Company’s common stock of one right per share of outstanding common stock. The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July 18, 2019. Flex Pharma has not listed, and does not intend to list, the rights for trading on any exchange. Th...

ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating Results

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 2, 2019 to discuss its second quarter operating results. Management will also provide a brief update on the business. CONFERENCE CALL INFORMATION To access the live call ...

Your NEJM Group Today: Primary Care First / CPAP & Depression / Internal Medicine & HIV/AIDS Opportunities

Today's top picks from NEJM Group include: NEJM Primary Care/Hospitalist Page: Perspective: Medicare's new Primary Care First payment model ignores the low level of...

Support for Broadening ECG Criteria for Using CRT

It might be oversimplifying to focus only on heart failure patients with left-bundle-branch block, say some. There is a non-LBBB subgroup that seems to benefit, suggest registry data. Medscape Medical News

PER® Global Presents the 4th Annual European Congress on Immunotherapies in Cancer™ in Barcelona

Continuing medical education conference will focus on the latest emerging data on immunotherapies PER Global, a worldwide leading resource for continuing medical education, will host the 4th Annual European Congress on Immunotherapies in Cancer™. The congress will take place 15-16 Nov. 2019 at the Hilton Barcelona in Spain. This year’s program will be co-chaired by Antoni Ribas, M.D., Ph.D...

Know Labs announces progress of UBAND non-invasive continuous glucose monitor

Increased accuracy and precision in laboratory test subject measurements have allowed the Company to expedite its focus on an FDA-approved CGM, causing it to curtail plans for its The post Know Labs announces progress of UBAND non-invasive continuous glucose monitor appeared first on NS Medical Devices.

Steve English Joins Trustmark Board of Directors

Steven E. English, Senior Vice President and Chief Financial Officer, State Auto Group, has been elected to the Board of Directors of Trustmark Mutual Holding Company (Trustmark). The announcement was made by Trustmark Chairman David Weick. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190718005591/en/Steven E. English (Photo: Busines...

Lysogene Establishes Scientific Advisory Board with International Experts in CNS Gene Therapy

Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, Phase 3, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of world-leading experts in gene therapy discovery and development. “Gene therapy using recombinant adeno-associated virus ...

Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases

TG6002 has multiple mechanisms of action for enhanced anti-tumor activity: oncolysis, local production of chemotherapy in tumor and cell-mediated immune response The Phase 1/2a trial is expected to start in Q4 2019 Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today announces it has received ...

Faron Pharma set to expand Clevegen cancer trial as data continues to impress

Faron Pharmacuetical Oy’s (LON:FARN) clinical trial of anti-cancer drug Clevegen continues to deliver encouraging results chief executive Markku Jalkanen told Proactive’s Andrew Scott. Dosing has now reached the maximum levels with no adverse effects on patients in the study, while significant signs of increased immune activity were noted. Nine people have now been treated and once the d...

MPH Health Care AG successfully holds Annual General Meeting - Dividend distribution of EUR 0.20 per share resolved

DGAP-News: MPH Health Care AG / Key word(s): AGM/EGM/Dividend 18.07.2019 / 15:36 The issuer is solely responsible for the content of this announcement. MPH Health Care AG successfully holds Annual General Meeting - Dividend distribution of EUR 0.20 per share resolved Berlin, July 18th, 2019: MPH Health Care AG ("MPH") successfully held the Annual General Meeting 2019 yesterday. The re...

More than Half of U.S. Population Now Governed by State Laws Raising Minimum Age of Purchase for All Tobacco Products to 21

-- Altria calls for 21 to be the nationwide standard -- With legislation signed this week in both New York and Ohio, today more than 50 percent of the U.S. population lives in states that have raised the legal age of purchase for all tobacco products to 21. In response, Howard Willard, chairman and chief executive officer of Altria Group, Inc. said: “Now is the time to move to 21, which is...

UnitedCoatings Group Announces Acquisition of CoorsTek Medical

Acquisition Broadens UnitedCoatings’ Capabilities to Offer Comprehensive Supply Chain Solutions UnitedCoatings Group, together with its medical division (Eurocoating SpA, Surface Dynamics, NanoSurfaces Industries, Anteco and Eurocoating Medical Technology Wuxi), a leading global supplier of integrated contract manufacturing solutions to medical device OEMs, announced today that, after its acqu...

CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development Program

CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that the Company’s Scientific Advisory Board endorsed Alzheimer’s Disease as the company’s next drug development indication. The Scientific Advisory Board met via videoconference on July 17, 2019. The endorse...

Find Out How Cannabis Consumers Choose Transportation

Cannabis technology platform Eaze has released a report that looks at the transportation choice of cannabis consumers before and after consumption. Eaze released details of the first study of its kind in California, titled, "Perceptions on Impairment: Cannabis Consumers in Focus." The research was done by Eaze in partnership with ride-hailing service Lyft.

Expanding #Cancer Immunotherapy Focus, @Boehringer Acquires AMAL Therapeutics for Up-to-€325M: http://ow.ly/rHRu50v4Q5Q pic.twitter.com/3OligckDgh

Expanding #Cancer Immunotherapy Focus, @Boehringer Acquires AMAL Therapeutics for Up-to-€325M: http://ow.ly/rHRu50v4Q5Q  pic.twitter.com/3OligckDgh

New Research Demonstrates Advantages of ExactechGPS® for Knee and Shoulder Joint Replacement

Scientific Studies Featured at International Computer Assisted Orthopaedic Surgery Annual Meeting Exactech, a developer and producer of bone and joint restoration products and biologic solutions for extremities, hip and knee, announced today that new research demonstrates improved surgical experience and advantages of ExactechGPS®, a computer-assisted technology that provides knee and shoulder ...

Textmunication Holdings, Inc. Provides Shareholder Update

Textmunication Holdings, Inc. (OTCM: TXHD) (“Company”), a cloud-based communication technology holding company, announced today an update to shareholders regarding the progress of its strategic growth plans and technology initiatives. The Company is looking to acquire cannabis wellness lifestyle companies and bring them into the holding company. Global Wellness Institute states the wellness m...

Different Takes: Lessons On The Differences, If Any, Between Biden, Sanders On Health Care; Medicaid’s Future Needs To Be Front And Center In The Ongoing Discussions

Editorial pages focus on the debate about the future of health care.

Titan Medical Completes Preclinical Good Laboratory Practice Procedures With Its Single-Port Robotic Surgical System

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that all procedures under Good Laboratory Practice (“GLP”) principles associated with the acute and chronic animal studies and human c...

Elanco Finalizes Acquisition of Aratana Therapeutics

Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant®. This transaction allows Elanco to capture the full value of growing product Gal...


Quick Search

News Quicklinks